Resqunit enters conditional agreement on purchase of IPR and financing to enable continued development of existing operations
Resqunit AB (publ) ("Resqunit" or the "Company") has today announced its entry into a conditional agreement for the acquisition of intellectual property rights and a capital injection from Bio Vitos Norge AS ("Bio Vitos" and the "Acquisition" respectively). The intellectual property rights (the “IPR”) acquired primarily encompass business assets related to the distribution and sale of health products containing Omega 3 (the "New Business"). The board of directors of the Company has evaluated the New Business as a significant opportunity to enhance the Company's potential for achieving